Senior insider sale
Chief Scientific Officer at FULGENT GENETICS, INC. — senior position signals high conviction
$65.5K
3.57K shares
What this filing means
GAO HANLIN plans to sell 3.57K shares of FULGENT GENETICS, INC. valued at approximately $65.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/28/2026ACC: 0001684532-26-000007
Officer· Chief Scientific Officer
Since Feb 2026
3.57K
Shares to sell
$65.5K
Approx. market value
21.15K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted stock vest
Equity compensation for services rendered
2/26/2024
21.15KTotal acquired21.15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/26/2024 | Restricted stock vest Equity compensation for services rendered | 21.15K | — |
| Total | 21.15K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.69K
Market value
$30.2K
6/2/2026
—Completed
Units to sell
945.00
Market value
$16.6K
5/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
939.00
Market value
$18.7K
8/27/2026
Total
Units
3.57K
Value
$65.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/2/2026 | 1.69K | $30.2K | — | Completed |
5/27/2026 | 945.00 | $16.6K | — | Completed |
| Planned — Approximate Date | ||||
8/27/2026 | 939.00 | $18.7K | NASDAQ | Planned |
| Total | 3.57K | $65.5K | ||